nicorandil has been researched along with Cardiac Death in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichikawa, S; Iwasaki, T; Kasama, S; Kumakura, H; Kurabayashi, M; Matsumoto, N; Minami, K; Sato, Y; Sumino, H; Toyama, T | 1 |
| Hashimoto, T; Imai, R; Iwamoto, N; Kobayashi, H; Nishida, M; Nishimura, M; Okino, K; Ono, T; Takahashi, H; Tokoro, T; Yamazaki, S | 1 |
2 other study(ies) available for nicorandil and Cardiac Death
| Article | Year |
|---|---|
Effects of oral nicorandil therapy on sympathetic nerve activity and cardiac events in patients with chronic heart failure: subanalysis of our previous report using propensity score matching.
Topics: 3-Iodobenzylguanidine; Administration, Oral; Adult; Aged; Aged, 80 and over; Chronic Disease; Death; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Nicorandil; Organ Size; Prognosis; Radionuclide Imaging; Sympathetic Nervous System | 2014 |
Clinical potential of nicorandil to inhibit major cardiac events in hemodialysis patients with suspected myocardial ischemia.
Topics: Aged; Death; Female; Follow-Up Studies; Humans; Kidney Diseases; Male; Middle Aged; Myocardial Ischemia; Nicorandil; Renal Dialysis | 2009 |